RELAPSE LEUKEMIA
Clinical trials for RELAPSE LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new RELAPSE LEUKEMIA trials appear
Sign up with your email to follow new studies for RELAPSE LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune cell boost may shield kids from Post-Transplant infections
Disease control Recruiting nowThis study tests whether adding a special type of immune cell (memory T cells) after a donor stem cell transplant can help prevent serious viral and fungal infections. It involves up to 100 children and young adults with blood cancers or immune disorders. The approach aims to spe…
Matched conditions: RELAPSE LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New combo therapy targets Hard-to-Treat leukemias
Disease control Recruiting nowThis study tests whether combining two drugs, revumenib and mezigdomide, is safe for people with certain types of acute leukemia that have come back or not responded to treatment. The trial includes about 52 participants aged 12 and older with specific genetic changes in their le…
Matched conditions: RELAPSE LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Gene study aims to predict chemo side effects in kids with leukemia
Knowledge-focused Recruiting nowThis study observes 500 Indian children with acute lymphoblastic leukemia to see how their genes influence treatment side effects and response to steroids. Researchers will track toxicities and treatment outcomes over five years. No new drug is tested; the goal is to better under…
Matched conditions: RELAPSE LEUKEMIA
Sponsor: University of Geneva, Switzerland • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC